Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-03

Clinical Trial Update: Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab [NA]

View source ↗

Summary

A single-patient study evaluating tocilizumab for relapsing polychondritis has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tocilizumab (tocilizumab)

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Relapsing Polychondritis | NA | Status: COMPLETED | Results posted: 2021-03-03